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How Our Current Medical Care System Fails
People With Diabetes
Lack of timely, appropriate clinical decisions
M
any randomized controlled inter-
vention trials have demonstrated
that lowering glycemia (1,2), LDL
cholesterol (3), and blood pressure (4)
will markedly beneﬁt the complications
from diabetes. Based on these data, the
American Diabetes Association has rec-
ommended the following targets for gly-
cemic, lipid, and blood pressure outcome
measures, A1C 7.0%, LDL cholesterol
100 mg/dl, and blood pressure
130/80 mmHg, respectively (5).
Most diabetic patients do not meet
these recommended goals. Approxi-
mately half of the National Health and
NutritionExaminationSurveycohortmet
the glycemic goal (6). In other larger re-
ported populations, 21–43% of patients
had A1C levels 9.5%, only 22–46% of
diabetic patients met the LDL cholesterol
goal,and29–33%metthebloodpressure
goal (7). Far fewer, 2–10%, met the com-
bined American Diabetes Association
goalsforglycemia,lipids,andbloodpres-
sure (7).
Many approaches have been tried to
improve diabetes care but, with one ex-
ception, have been mostly ineffective.
These include simply reminding patients
about appointments; providing labora-
tory information on the patient to the
physician, even when speciﬁc treatment
recommendations for the individual pa-
tient were included; case management
when the case manager could not make
independent treatment decisions; educa-
tion of physicians; and multifaceted qual-
ity improvement interventions in the
practice setting (7).
The small amount of time a physician
has to spend with a patient is an impor-
tant limiting factor. This was amply illus-
trated in a study (8) in which eight
process measures agreed upon by the
physician group and whether the patient
was due to receive them were displayed
onthephysicians’computerscreensatthe
timeofthepatientvisit.Themeasuresdue
were performed or ordered only one-
third of the time. Physicians pinpointed
lack of time and other problems that
needed attention as primary obstacles to
carrying out the agreed-upon recommen-
dations.
The one approach that has proven to
be effective is using specially trained
nurses or pharmacists, under appropriate
supervision, with authority to make med-
ication changes without consulting the
physician as long as the changes fell
within approved treatment algorithms. In
randomized clinical trials, A1C levels fell
threefoldmorein1,969patientsfollowed
by nurses and pharmacists compared
with 1,573 patients under usual care (7).
Several nonglycemic outcome measures
alsosigniﬁcantlyimprovedwithnurse-or
pharmacist-directed diabetes care com-
pared with usual care. These included
LDL cholesterol, triglycerides, and sys-
tolic and diastolic blood pressure (7).
These impressive results stand in contrast
to case management in which nurses do
not have prescriptive authority (7).
Perhaps the best evidence for the im-
portance of the nurse or pharmacist to
have authority to make independent clin-
ical decisions comes from a direct com-
parison of programs in the same
institution. A diabetes case management
program in which medication changes by
nurse practitioners required approval by
the primary care physician was initially
established and compared with usual
care. Baseline A1C levels averaging
9.0%didnotchangeover18monthsin
either the control or intervention group
(9). Subsequently, in the same medical
care setting, a clinical pharmacist was al-
lowed to make independent clinical deci-
sions based on an approved protocol.
Baseline A1C levels averaging 10% fell
by 0.9% in the control group and 2.1% in
the intervention group over 12–24
months (10). The results of these two
studies within the same institution treat-
ing the same population were supported
byarecentmetaregressionanalysisonthe
effects of quality improvement strategies
to improve glycemia in type 2 diabetes
(11). Interventions in which case manag-
ers could adjust medications without
awaiting physician approval achieved the
most robust improvements, whereas
other approaches had minimal effect.
The critical factor that underlies the
success of specially trained nurses or
pharmacists to improve the outcomes of
diabetes care is that timely and appropri-
ate clinical decisions are made. The deci-
sions are appropriate because they are
based on approved treatment algorithms.
However, timeliness of these decisions is
also very important. The fact that more
time can be spent with the patient, not
only in the ofﬁce dealing speciﬁcally with
diabetes but also outside of the ofﬁce via
other means of communication, is critical
for improved outcomes. For the most
part, except for the minority of patients
who have polyuria and polydipsia sec-
ondary to severe hyperglycemia or those
who have diabetes complications, diabe-
tescareispreventivecare,i.e.,controlling
glycemia, lipids, and blood pressure in
asymptomatic people. These issues often
receiveshortshriftinthe10minorsothat
most patients spend with primary care
physicians, who often have other more
immediate concerns. Moreover, patients
are often seen only every 3 months or so,
thus ensuring that glycemia, lipids, and
blood pressure could remain out of con-
trol for long periods of time. This sched-
ule wastes opportunities to bring these
patients under control much more
quicklybecausethemaximalresponsesto
changes in medication doses or introduc-
tion of new classes of drugs for treating
glycemia (except for thiazolidinediones),
lipids, and blood pressure all occur
within a month.
Most treatment decisions involving
control of glycemia, lipids, and blood
pressure do not require a face-to-face
meetingwithaprovider.Titrationofmost
oral medications for glycemia can be
made based on fasting plasma glucose
concentrations measured by a laboratory
or by a glucose meter at home, with sub-
sequent dose adjustments based on A1C
levels (online appendix of ref. 12, avail-
able at http://dx.doi.org/10.2337/dc08-
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based on the results of home glucose
monitoring. Treatment of dyslipidemia is
based on measured lipid concentrations.
Patients can measure their own blood
pressure with home machines. (Glucose
meters and blood pressure machines
should be compared with ofﬁce meters
and blood pressure machines at periodic
ofﬁce visits.) These results can be made
available at appropriate intervals to the
primary care physician, who would then
respond to the patient via e-mail, phone,
or fax. In this manner, timely clinical de-
cisionswouldbemade,thepatientwould
be less inconvenienced, and diabetes out-
comes would improve. Of course, in our
present medical care system, physicians
are not routinely reimbursed for such ac-
tivities,andthereforethesekindsofinter-
actions seldom occur.
Let me illustrate with a personal case
in point. Dose adjustments in insulin-
requiring diabetic patients are particu-
larlychallenging.Patientsareusuallyseen
about every 3 months, and if they are for-
tunate the last 2 weeks or so of their glu-
cose values measured at home may be
reviewed. Insulin doses are often not sta-
ble over 3-month periods, but how can
one know when glucose responses over
only a small segment of that period are
evaluated? This is one reason why A1C
levels are higher in diabetic patients tak-
ing insulin than in those on oral medica-
tions alone. To address this problem, I
initiated a pilot project in the second half
of the 1990s in which the results of home
glucose monitoring were sent via tele-
phone wires to a central server where the
individual values were analyzed by an al-
gorithm, plotted on a simple graph,
which also depicted the appropriate tar-
getrange,andfaxedtoanurse(13).Based
on the patterns on the graph, the nurse
could decide in less than a minute what
insulin dose changes should be made.
These were then phoned to the patients,
whohadbeenreferredtothispilotproject
by their endocrinologist. Baseline A1C
levels averaging 8.4% in 10 type 1 dia-
betic and 19 insulin-requiring type 2 dia-
betic patients fell by 0.7% by 20 weeks.
When a start-up company tried to com-
mercialize this product, they were unable
to obtain a Current Procedural Terminol-
ogy code for this activity and soon there-
after went out of business. Thus, insulin-
requiring diabetic patients generally
continue to be seen every 3 months, and
their glycemia remains inadequately con-
trolled.
In the last decade, much easier Web-
based communication with patients has
become possible. In this issue of Diabetes
Care, Ralston et al. (14) have described a
randomized small trial in which one
group received usual care and the other
usual care plus Web-based care manage-
ment for 1 year. The latter group’s pro-
gram consisted of patient access to
electronic medical records, secure e-mail
access to providers (including a nurse
caremanagerwhoadjustedhypoglycemic
medications and conferred with the pri-
mary care provider only as needed), an
educational Web site, and an interactive
online diary for entering exercise, diet,
and medication. After 1 year, unadjusted
A1C levels in the intervention group fell
from a baseline value of 8.2 to 7.3%,
whereas in the control group they in-
creased from 7.9 to 8.1%. The authors
stated that they were unable to distin-
guish which components of Web-based
management were most important for the
successoftheintervention.Istronglysus-
pect it was the nurse care manager mak-
ingtreatmentdecisionsinrealtime,based
onpublishedliteratureshowingtheeffec-
tiveness of that approach and the ineffec-
tiveness of interventions that did not
include that component (7,9–11) as well
as the results of several other Web-based
interventions described below.
In a study by the Korean Diabetes As-
sociation, physicians receiving informa-
tion (including results of home glucose
monitoring) over the Internet from pa-
tients utilized the Staged Diabetes Man-
agement Guidelines for Korea (15) for
management. During the ﬁrst 3 months,
A1C levels fell by 0.6% in the Internet
groupandroseby0.3%inacontrolgroup
receiving usual care (16). Over the subse-
quent 27 months, mean A1C levels were
0.6% lower in the Internet group than in
the control group (17). All differences be-
tween the two groups were signiﬁcant. In
a Veterans Affairs study comparing usual
care with Web-based nursing care man-
agement based on treatment algorithms,
A1C levels fell signiﬁcantly more in the
intervention group over a year (0.4%
more at 12 months but a greater differ-
ence at 3, 6, and 9 months) (18). A com-
parisonoftelemedicinecasemanagement
bynursesfollowingalgorithmswithusual
care in older, medically underserved pa-
tients showed a small (0.2%), but signiﬁ-
cantly greater, drop of A1C levels in the
intervention group (19). These nurses,
however, had to receive authority to
change management from primary care
physicians. Finally, a very intense educa-
tion and support group program deliv-
eredviatheWeb—whichincludedaccess
toarticlesandotherWebsitesconcerning
diabetes, support group interactions led
by a nurse, and self-management feed-
back from a nurse after the nurse had re-
ceived home glucose monitored values,
meal intake, medication administration,
weight, and blood pressure information
from the patient—resulted in signiﬁcant
improvements in adjusted A1C
(0.62%), HDL cholesterol (6.4 mg/
dl), total cholesterol (11.4 mg/dl),
weight(4.5lbs),systolicbloodpressure
(6.8 mmHg), and diastolic blood pres-
sure (5.2 mmHg) over 6 months, with
nosigniﬁcantchangesintheseparameters
in a control group (20).
All of these innovative approaches to
deliver diabetes care were supported by
either research or institutional funds. Un-
less payment mechanisms can be estab-
lished to reimburse providers for the time
and effort these effective interactions re-
quire, these new promising care models
willremainjustthat—(unkept)promises.
Until a magic medication comes
alongtostabilize-cellfunctionor,better
yet, to reverse -cell dysfunction, it will
remain difﬁcult to improve diabetes out-
comesverymuchunlessthecurrentmed-
ical care system can change to facilitate
more frequent interactions with knowl-
edgeable providers. This might also in-
clude specially trained, appropriately
supervised nurses and pharmacists with
prescriptionauthoritybasedonapproved
treatment algorithms. Timely and appro-
priate clinical decisions for people with
diabetes are not being made in most pa-
tients under our current medical care sys-
tem. This leads to increased morbidity
and mortality from diabetes complica-
tionsthatcouldbeeitherconsiderablyde-
layed or potentially prevented.
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